MIR577
gene geneOn this page
Also known as hsa-mir-577
Summary
MIR577 (microRNA 577, HGNC:32833) is a microRNA gene on chromosome 4q26.
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.
Source: NCBI Gene 693162 — RefSeq curated summary.
At a glance
- Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32833 |
| Approved symbol | MIR577 |
| Name | microRNA 577 |
| Location | 4q26 |
| Locus type | RNA, micro |
| Status | Approved |
| Aliases | hsa-mir-577 |
| Ensembl gene | ENSG00000207931 |
| Ensembl biotype | miRNA |
| Entrez | 693162 |
| RNAcentral | URS00006D03D5 — miRNA, 96 nt, 5 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 miRNA
ENST00000385196
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000385196 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001500202 | 114656759 | 114656854 |
Expression profiles
Bgee: expression breadth broad, 42 present calls, max score 82.70.
Top tissues by expression
42 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endometrium | UBERON:0001295 | 82.70 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 82.07 | gold quality |
| corpus callosum | UBERON:0002336 | 82.02 | gold quality |
| heart | UBERON:0000948 | 79.40 | gold quality |
| kidney | UBERON:0002113 | 79.32 | gold quality |
| sural nerve | UBERON:0015488 | 77.37 | gold quality |
| blood | UBERON:0000178 | 76.30 | gold quality |
| stomach | UBERON:0000945 | 75.02 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 73.73 | gold quality |
| monocyte | CL:0000576 | 72.93 | gold quality |
| body of stomach | UBERON:0001161 | 72.84 | gold quality |
| intestine | UBERON:0000160 | 72.32 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.22 | gold quality |
| calcaneal tendon | UBERON:0003701 | 70.02 | gold quality |
| right frontal lobe | UBERON:0002810 | 69.41 | gold quality |
| colon | UBERON:0001155 | 69.31 | gold quality |
| Ammon’s horn | UBERON:0001954 | 68.01 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 67.99 | gold quality |
| body of pancreas | UBERON:0001150 | 67.93 | gold quality |
| ascending aorta | UBERON:0001496 | 67.70 | gold quality |
| esophagus mucosa | UBERON:0002469 | 67.66 | gold quality |
| transverse colon | UBERON:0001157 | 66.66 | gold quality |
| putamen | UBERON:0001874 | 66.36 | gold quality |
| skin of leg | UBERON:0001511 | 65.51 | gold quality |
| amygdala | UBERON:0001876 | 64.89 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 64.40 | gold quality |
| skin of abdomen | UBERON:0001416 | 64.01 | gold quality |
| tibial nerve | UBERON:0001323 | 63.92 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 63.52 | gold quality |
| ectocervix | UBERON:0012249 | 63.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.66 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 16)
- Report role for mir-577/TSGA10 axis in regulation esophageal squamous cell carcinoma progression. (PMID:24294352)
- Study shows that miR-577 is down-regulated in glioblastoma tumors and cell lines and its overexpression directly regulates Wnt signaling by inhibiting expression of b-catenin and LRP6. (PMID:25764520)
- Data suggest that microRNA-577 is down-regulated in colorectal cancer (CRC) tumors and cell lines; however, CRC cells that are resistant to antineoplastic 5-fluorouracil have elevated levels of microRNA-577; thus, miR-577 appears to acts as tumor suppressor in CRC likely through targeting HSP27. (PMID:28150434)
- findings indicate that miR-577 is a potential tumor suppressor in Papillary Thyroid Cancer by targeting SphK2, and may be a potential therapeutic target in PTC. (PMID:28975989)
- WNT2B acted as a target of miR-577, and WNT2B played the oncogenic role in osteosarcoma cells by activating Wnt/beta-catenin pathway. (PMID:29108989)
- Results indicated that miR-577 suppressed EMT by inhibiting Rab25 expression in breast cancer (BC). MiR-577 and Rab25 are considered potential targets of BC treatment. (PMID:29524309)
- the study revealed that lncRNA DANCR might promote the proliferation of osteoarthritis chondrocytes and reduce apoptosis through the miR-577/SphK2 axis. (PMID:29678573)
- Study confirmed that miR577 expression was markedly downregulated in both in hepatocellular carcinoma (HCC) tissues and cell lines and related to malignant clinicopathological features, such as venous invasion and advanced TNM stage. MiR577 was identified as an inhibitor of cell metastatic ability and EMT progress in HCC through direct interaction with HOXA1. (PMID:29693150)
- DANCR promoted HSP27 expression and its mediation of proliferation/metastasis via miR-577 sponging. (PMID:29717105)
- MiR-577 serves an important role in regulating cell proliferation, migration and invasion, and the epithelial-mesenchymal transition process in non-small cell lung cancer cells and miR-577 may have inhibited WNT2B expression at both the mRNA and protein expression levels by directly targeting the 3’UTR of the WNT2B mRNA. (PMID:30015869)
- these results indicated that miR577 may have served tumor suppressive roles in nonsmall cell lung cancer by directly targeting HOXA1 (PMID:30628697)
- Low miR577 expression is associated with invasion in nasopharyngeal carcinoma. (PMID:31344361)
- LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis. (PMID:32386483)
- Long non-coding RNA TRIM52-AS1 sponges microRNA-577 to facilitate diffuse large B cell lymphoma progression via increasing TRIM52 expression. (PMID:35676608)
- MicroRNA-577/EIF5A2 axis suppressed the proliferation of DDP-resistant nasopharyngeal carcinoma cells by blocking TGF-beta signaling pathway. (PMID:37500510)
- Knocking-down long non-coding RNA LINC01094 prohibits chondrocyte apoptosis via regulating microRNA-577/metal-regulatory transcription factor 1 axis. (PMID:38758016)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.